News from perrigo company A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NASDAQ-NMS:PRGO,TelAviv:PRGO)

Oct 23, 2014, 08:34 ET
Perrigo Company.

Perrigo Company plc To Release First Quarter Fiscal Year 2015 Results On November 6, 2014

Perrigo Company plc (NYSE: PRGO; TASE) today announced that it will release financial results for its first quarter fiscal year 2015 on Thursday,...

Oct 02, 2014, 08:48 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Company plc Announces Expiration Of Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023, 5.30% Senior Notes Due 2043

 Perrigo Company plc (NYSE: PRGO; TASE), a public limited company incorporated under the laws of Ireland (the "Company"), today announced the...

Oct 01, 2014, 08:53 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Company plc Announces Extension of Exchange Offer for Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023, 5.30% Senior Notes Due 2043

 Perrigo Company plc (NYSE: PRGO; TASE), a public limited company incorporated under the laws of Ireland (the "Company"), today announced...

Sep 29, 2014, 07:39 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Announces the Out-Licensing of Preclinical Assets to Imago Pharmaceuticals

 Perrigo Company plc (NYSE: PRGO; TASE) announced today that it has transferred a portfolio of preclinical research assets, which it acquired...

Sep 29, 2014, 07:09 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Enters New Therapeutic Category With The Acquisition Of Women's Health Product Portfolio From Lumara Health

 Perrigo Company plc (NYSE: PRGO; TASE) announced today that it has signed a definitive agreement to acquire a portfolio of women's healthcare...

Sep 02, 2014, 17:09 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Company plc Announces Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023 and 5.30% Senior Notes Due 2043

Perrigo Company plc, a public limited company incorporated under the laws of Ireland (the "Company"), today announced that it is offering to...

Aug 14, 2014, 09:41 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Company plc Reports Record Fourth Quarter And Fiscal Year Revenue, Adjusted Operating Income And Adjusted Margins. Conference call scheduled for 10 a.m. ET today.

- Fiscal fourth quarter net sales increased 18% year-over-year to a record $1.14 billion. - Fiscal fourth quarter adjusted net income...

Aug 13, 2014, 15:49 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Company plc Announces Quarterly Dividend

Perrigo Company plc (NYSE: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.105 per share, payable on...

Jul 31, 2014, 08:58 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Company plc To Release Fourth Quarter And Fiscal Year 2014 Results On August 14, 2014

Perrigo Company plc (NYSE: PRGO; TASE) today announced that it will release financial results for its fourth quarter and fiscal year 2014 on...

Jul 30, 2014, 08:10 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Confirms First To File Patent Challenge For Generic Version Of Topicort® Topical Spray 0.25%

Perrigo Company (NYSE: PRGO;TASE) announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application...

Jul 24, 2014, 12:55 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0%

 Perrigo Company (NYSE: PRGO; TASE) today announced that it has received an AB therapeutic equivalent rating from the U.S. Food and Drug...

Jul 08, 2014, 08:47 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Announces FDA Final Approval For The Store Brand Equivalent To Advil® Congestion Relief Tablets, 200 mg/10 mg

Perrigo Company (NYSE: PRGO; TASE) today announced that it was the first to receive final approval from the U.S. Food and Drug Administration for...

May 30, 2014, 08:09 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Company plc To Present At Jefferies 2014 Global Healthcare Conference

Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the Jefferies 2014...

May 12, 2014, 09:23 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Company plc Announces FDA Approval Of Generic Version Of Astepro® Nasal Spray

 Perrigo Company plc (NYSE: PRGO;TASE) announced that it has received final approval from the U.S. Food and Drug Administration (FDA) on its...

May 07, 2014, 08:00 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Company plc Reports Record Quarterly Revenue and Adjusted Operating Income Despite Weak Retail and Cough, Cold and Flu Seasons

  - Fiscal third quarter net sales increased 9% year-over-year to a record $1,004 million. - Fiscal third quarter adjusted net...

Apr 28, 2014, 14:30 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Company plc Announces Quarterly Dividend

Perrigo Company plc (NYSE: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.105 per share, payable on...

Apr 23, 2014, 09:14 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Company plc To Release Third Quarter Fiscal Year 2014 Results On May 7, 2014

Perrigo Company plc (NYSE: PRGO; TASE) today announced that it will release financial results for its third quarter fiscal year 2014 on...

Apr 01, 2014, 08:16 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Announces Launch Of Authorized Generic Version Of Taclonex® Ointment (Calcipotriene 0.005% / Betamethasone Dipropionate 0.064%)

Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has initiated market launch and made its first shipments of the authorized generic...

Mar 26, 2014, 09:40 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Partners With Division Of Golden State Foods To Manufacture Store Brand Versions Of Ensure® Adult Nutritional Drinks

 Perrigo Company plc (NYSE: PRGO; TASE) today announced that its Nutritionals segment is partnering with KanPak LLC to manufacture store...

Mar 12, 2014, 08:43 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Announces Launch Of Generic Version Of Neptazane™ (Methazolamide) Tablets

Perrigo Company (NYSE: PRGO; TASE) today announced that it has launched, through a distribution and supply agreement, methazolamide tablets, the...